Our site will be under maintenance from 9/22, starting 9:30PM ET - 9/23, 4AM ET. Content requiring login access will be unavailable. Questions? help@ons.org
cancel
Diagnose and Manage Dermatologic Toxicity Secondary to Immunotherapy
Wendy Vogel MSN, FNP, AOCNP®
Voice
Description
Dermatologic toxicity is the most common side effect secondary to immunotherapy. The majority of dermatologic adverse events are mild to moderate rashes on the truck of the body and upper extremities, pruritis, and vitiligo.